1/30
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
Microbial Contamination
Has been a perpetual issue in the manufacturing industry and drug development in the context of microbial attributes
Sterile
High-risk to end users
High-level of sterilization and sanitation manufacturing procedures
Absolute absence of viable microorganisms and their by-products
Products may be aseptically manufactured or terminally sterilized
Non-Sterile
Low to moderate risk to end user
Moderate to low contamination control
Continuously implementing Current Good Manufacturing Practice (CGMP)
Sterile Products
Such products may be aseptically manufactured or terminally sterilized
Aseptically Manufactured Products
Products that require extremely high contamination control
Involve high risk to end user
All the processes done in manufacturing a product is sterile from beginning to end
Manufactured in cleanrooms (rooms with different compartments that minimize the contamination — consists of Anti-room and Sterile room)
Terminally Sterilized Products
Products that require high contamination control
Involve a high-moderate risk to end user
Product is only made sterile in the last step
Autoclaving
Non-Sterile Products
The presence of certain microorganisms in _____ may:
Reduce or Inactivate the therapeutic activity of the product
Alter the physiochemical and organoleptic properties of drugs
Cause infections and affect the health of the patient
Bioburden
The number and type of viable microorganisms existing in non-sterile pharmaceutical products
Absence of objectionable organisms
Manufacturers should ensure a low _____ of the finished product by continuously implementing Current Good Manufacturing Practices (CGMP) during the manufacture, storage, and distribution of these products.
Bioburden
Presence of Gram-Positive Bacteria
Presence of Gram-Negative Bacteria
Risk Assessment is Based on the:
Presence of Gram-Positive Bacteria
Often implicate human intervention as a major reason for product contamination
Ex. These bacteria present as normal microflora of the skin
Presence of Gram-Negative Bacteria
Suggests lack of process control in pharmaceutical environments, particularly those involved in water systems and raw materials
Gram-Negative Rods
Most common contaminants of non-sterile pharmaceuticals, regardless of geographical location or time
Microbial Limits Testing
A quantitative enumeration of viable microorganisms and the determination of the absence of specific microorganisms in finished pharmaceutical products and raw materials
Microbial Examination of Nonsterile Products: Microbial Enumeration Tests
Title of USP General Chapter <61>
Microbiological Examination of Nonsterile Products: Tests for Specified Microorganisms
Title of USP General Chapter <62>
Microbial Examination of Nonsterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use
Title of USP General Chapter <1111>
Total Aerobic Microbial Count (TAMC)
Considered to be equal to the number of cfu found using Soybean-Casein Digest Agar
Total Combined Yeasts and Molds Count (TYMC)
Considered to be equal to the number of cfu found using Sabouraud Dextrose Agar
Methods for Microbial Enumeration
Membrane Filtration
Plate-Count Methods
Pour Plate Method
Surface Spread Method
Most Probable Number (MPN) Method
Membrane Filtration
Microbiological technique used for the concentration and enumeration of microorganisms in a liquid sample
used to accommodate large volumes of samples
Used of the Most Probable Number (MPN) of microorganisms is low
Pour Plate Method
Not useful for aerobic microorganisms especially of it is non-motile
Pour-plate method recommended of the bacteria is motile and facultative anaerobe
Surface Spread Method
Serial Dilution
Most Probable Number(MPN) Method
Least accurate method for microbial counts
Reserved for the enumeration of Total Aerobic Microbial Count (TAMC) in situations where no other method is available
In Product Groups with Very Low Bioburden, it may be the Most Appropriate method.
Test Strain
Bacillus subtilis (endospore producing)
Staphylococcus aureus (gram (+))
Pseudomonas aeruginosa (gram (-))
Growth Promotion of the Media
To test the suitability of the medium to permit the growth of specified microorganisms in the started culture conditions
Neutralization of Antimicrobial Activity
If your product showed an antimicrobial property, you need to neutralize the antimicrobial property before testing the product
If no suitable neutralizing method can be found, it can be assumed that the failure to isolate the inoculated organism is attributable to the microbial activity of the product
Negative Control
To verify testing conditions, a _____ is performed using the chosen diluent in place of the test preparation
There must be NO GROWTH of microorganisms
No Growth = No Contamination
Ensures that the growth to be seen during the testing of the product comes only from the product itself
Testing of Product
This is performed to validate the dilution and neutralization of antimicrobial property of the product
Growth Promotion Test
Ensures that test microorganisms (which represent the typical bacteria expected to be in contaminated pharmaceutical product) grow in the chosen medium
Suitability of the Counting Method
Performed in the presence of the product to determine the suitability or the “appropriateness” of the product’s diluent, working dilution, additives, neutralization/removal of antimicrobial activity, and counting method
Antimicrobial Preservatives
Substances added to nonsterile dosage forms to protect them from microbial growth or from microorganisms that are introduced inadvertently during or subsequent to the manufacturing process
Antimicrobial Effectiveness Test
Also known as Preservative Efficacy Test (PET)
A compendial procedure used to evaluate the performance of those preservatives
Helps assure that the preservative system is robust enough to prevent the growth of objectionable microorganisms